drug
pegfilgrastim
Marketedupdated 5mo agoby Accord Biopharma Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval10 co-mentions · 5 sources
- drugSTIMUFEND8 co-mentions · 4 sources
- companyFresenius Kabi USA LLC4 co-mentions · 4 sources
- drugRNS-604 co-mentions · 4 sources
- companyAccord Biopharma Inc2 co-mentions · 1 sources
- tagRecall2 co-mentions · 1 sources
- drugARMLUPEG2 co-mentions · 1 sources
- companyLupin Ltd1 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying pegfilgrastim
- phase2FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer
- phase2ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
- phase2Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
- phase2Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
- phase2Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
- phase2Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
- phase1Safety, Tolerability, and PK/PD of Telpegfilgrastim Injection in Non-pregnant Females of Childbearing
- phase2Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that